NEW YORK (GenomeWeb) – British informatics firm Genomics plc today announced a collaboration with the University of Oxford and Oxford University Hospitals NHS Foundation Trust to analyze genomic sequences in rare diseases and cancer.

Under the terms of the agreement, the partners will work on a pilot study to establish genome sequencing as a clinical tool in rare diseases, cancers, and other disorders. Genomics will use its software to analyze up to 500 genome sequences, linking genotypes and phenotypes.

Financial terms of the deal were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.